| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 2,215 | 2,415 | 2,508 | 2,522 | 2,582 | 2,850 | 2,922 | 3,125 | 2,179 | 2,808 | 2,781 | 2,931 | 4,079 | 3,725 | 3,662 | 3,580 | 3,812 | 4,274 | 4,299 | 4,322 | 4,452 | 4,873 | 4,880 | 4,981 | 5,134 | 5,633 | 5,596 | 5,664 | 5,896 | 6,365 | 6,545 |
| Expenses | 1,981 | 2,141 | 2,222 | 2,220 | 2,218 | 2,427 | 2,482 | 2,542 | 2,159 | 2,470 | 2,370 | 2,456 | 3,245 | 3,102 | 3,052 | 3,083 | 3,317 | 3,699 | 3,780 | 3,814 | 3,909 | 4,219 | 4,237 | 4,303 | 4,411 | 4,774 | 4,765 | 4,823 | 4,990 | 5,362 | 5,531 |
| EBITDA | 234 | 274 | 286 | 302 | 364 | 423 | 440 | 583 | 21 | 337 | 411 | 475 | 835 | 623 | 610 | 497 | 495 | 575 | 519 | 508 | 543 | 654 | 643 | 677 | 724 | 859 | 831 | 841 | 906 | 1,002 | 1,014 |
| Operating Profit % | 10 % | 11 % | 11 % | 11 % | 14 % | 15 % | 15 % | 13 % | 1 % | 11 % | 14 % | 14 % | 14 % | 17 % | 16 % | 13 % | 13 % | 13 % | 11 % | 11 % | 12 % | 13 % | 13 % | 13 % | 13 % | 15 % | 14 % | 14 % | 15 % | 15 % | 15 % |
| Depreciation | 95 | 97 | 98 | 105 | 144 | 155 | 157 | 164 | 160 | 149 | 125 | 139 | 141 | 145 | 149 | 166 | 148 | 155 | 153 | 159 | 167 | 163 | 167 | 190 | 177 | 185 | 185 | 211 | 215 | 218 | 219 |
| Interest | 76 | 81 | 84 | 85 | 126 | 134 | 137 | 135 | 127 | 122 | 101 | 99 | 95 | 95 | 94 | 95 | 93 | 93 | 100 | 95 | 106 | 111 | 113 | 119 | 116 | 118 | 110 | 115 | 108 | 110 | 113 |
| Profit Before Tax | 63 | 96 | 103 | 112 | 94 | 134 | 145 | 284 | -267 | 66 | 185 | 238 | 599 | 383 | 368 | 236 | 254 | 327 | 266 | 254 | 270 | 379 | 363 | 368 | 430 | 557 | 536 | 516 | 583 | 675 | 682 |
| Tax | 39 | 42 | 53 | 39 | 45 | 51 | 55 | 74 | -41 | 7 | 51 | 68 | 99 | 116 | 124 | 139 | -70 | 114 | 104 | 108 | 97 | 130 | 109 | 110 | 115 | 162 | 157 | 101 | 142 | 181 | 166 |
| Net Profit | 23 | 54 | 50 | 73 | 49 | 83 | 90 | 210 | -226 | 59 | 134 | 170 | 501 | 267 | 243 | 97 | 324 | 213 | 162 | 146 | 173 | 249 | 254 | 258 | 316 | 396 | 379 | 415 | 441 | 494 | 516 |
| EPS in ₹ | 2.44 | 4.56 | 4.10 | 6.10 | 4.11 | 6.20 | 6.62 | 15.77 | -14.96 | 4.33 | 9.38 | 11.77 | 34.03 | 17.24 | 15.88 | 6.27 | 22.05 | 14.19 | 10.67 | 10.05 | 11.59 | 16.20 | 17.06 | 17.65 | 21.23 | 26.34 | 25.89 | 27.10 | 30.10 | 33.19 | 34.94 |
Apollo Hospitals
Apollo Hospitals
7,511.50
+30.00
(0.40%)
Market Cap
1,08,003.85 Cr
PE Ratio
57.65
Volume
4,37,163.00
Day High - Low
7,563.00 - 7,461.50
52W High-Low
8,099.50 - 6,665.00
Key Fundamentals
Market Cap
1,08,003.85 Cr
EPS
100.56
PE Ratio
57.65
PB Ratio
11.84
Book Value
631.88
EBITDA
3,222.10
Dividend Yield
0.17 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
17.39
Debt to Equity
0.61
Analyst Rating and Forecast
- By Refinitiv from26 analysts
Actual
Company News
View All News
Apollo Hospitals Enterprise Limited received certified true copy of NCLT order dated March 26, 2026 regarding composite scheme of arrangement involving four companies under Regulation 30.
Apollo Hospitals acquires remaining minority stake in Apollo Health And Lifestyle for Rs 18.69 crore at Rs 241 per share, achieving 100% ownership of the subsidiary company.
Morgan Stanley Cuts Apollo Hospitals Target to ₹8,8334 days ago
Morgan Stanley maintains Overweight rating on Apollo Hospitals but reduces target price to ₹8,833 from ₹9,209, citing EBITDA pressure from new hospital ramp-up losses and higher Apollo 24/7 costs.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
7,511.50 | #1 1,08,003.85 | #5 57.65 | #1 21,994.30 | #1 14.76 | #1 1,505 | #2 36.08 | 52.72 | |
953.35 | 92,773.83 | 65.50 | 0.00 | - | 0 | 26.01 | 39.91 | |
847.85 | 64,009.13 | 65.48 | 7,849.70 | 13.25 | 809 | -22.38 | 51.42 | |
1,754.90 | 35,863.28 | 45.33 | 5,575.00 | 12.29 | 790 | -34.33 | 56.73 | |
681.80 | 35,325.49 | 96.41 | 4,286.70 | 15.12 | 337 | -8.85 | 58.43 | |
1,066.15 | 28,657.09 | 54.94 | 3,771.40 | 12.59 | 481 | -33.52 | 53.63 | |
664.25 | 26,579.23 | 84.22 | 3,067.00 | 21.98 | 415 | -43.89 | 53.23 | |
435.85 | 13,808.06 | 85.78 | 1,757.00 | #1 27.64 | 110 | #1 54.61 | 52.86 | |
1,249.70 | 12,691.85 | 49.02 | 1,566.90 | 17.46 | 244 | 7.26 | 62.62 | |
210.45 | 9,089.99 | #1 32.75 | 1,426.00 | 12.90 | 213 | 15.54 | 61.17 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
14.76 %
Net Income Growth
60.97 %
Cash Flow Change
11.26 %
ROE
36.18 %
ROCE
2.58 %
EBITDA Margin (Avg.)
12.43 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 6,479 | 7,360 | 8,119 | 8,613 | 9,183 | 11,338 | 11,417 | 13,269 | 14,428 | 16,753 | 20,657 |
| Fixed Assets | 3,244 | 3,997 | 4,591 | 4,773 | 4,982 | 7,432 | 6,778 | 8,296 | 8,520 | 9,664 | 10,988 |
| Current Assets | 1,939 | 1,975 | 2,129 | 2,220 | 2,282 | 2,647 | 3,641 | 4,061 | 4,337 | 5,280 | 7,029 |
| Capital Work in Progress | 533 | 562 | 347 | 712 | 822 | 236 | 234 | 46 | 610 | 873 | 921 |
| Investments | 146 | 352 | 406 | 352 | 462 | 434 | 1,343 | 816 | 574 | 986 | 2,487 |
| Other Assets | 2,557 | 2,448 | 2,775 | 2,776 | 2,918 | 3,237 | 3,062 | 4,112 | 4,725 | 5,230 | 6,261 |
| Total Equity & Liabilities | 6,479 | 7,360 | 8,119 | 8,613 | 9,183 | 11,338 | 11,417 | 13,269 | 14,428 | 16,753 | 20,657 |
| Current Liabilities | 1,076 | 1,250 | 963 | 1,567 | 1,956 | 2,337 | 2,038 | 2,434 | 3,325 | 4,665 | 4,579 |
| Non Current Liabilities | 2,159 | 2,701 | 3,718 | 3,662 | 3,759 | 5,531 | 4,577 | 4,932 | 4,572 | 4,768 | 7,426 |
| Total Equity | 3,244 | 3,409 | 3,438 | 3,384 | 3,469 | 3,470 | 4,802 | 5,903 | 6,531 | 7,321 | 8,653 |
| Reserve & Surplus | 3,101 | 3,262 | 3,240 | 3,182 | 3,264 | 3,270 | 4,531 | 5,551 | 6,126 | 6,864 | 8,140 |
| Share Capital | 70 | 70 | 70 | 70 | 70 | 70 | 72 | 72 | 72 | 72 | 72 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 103 | 39 | -52 | 24 | -20 | 95 | 45 | 158 | -113 | 72 | 73 |
| Investing Activities | -759 | -888 | -1,152 | -405 | -711 | -289 | -880 | -747 | -857 | -1,537 | -3,381 |
| Operating Activities | 470 | 597 | 623 | 537 | 905 | 1,293 | 1,265 | 1,696 | 1,377 | 1,920 | 2,136 |
| Financing Activities | 392 | 330 | 477 | -109 | -215 | -910 | -340 | -792 | -633 | -311 | 1,317 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 29.82 % | 29.82 % | 29.82 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.34 % | 29.34 % | 28.02 % | 28.02 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 45.63 % | 43.92 % | 45.37 % | 45.27 % | 42.74 % | 43.49 % | 44.20 % | 43.54 % |
| DIIs | 9.16 % | 10.84 % | 12.24 % | 12.13 % | 12.45 % | 14.89 % | 14.59 % | 16.56 % | 17.76 % | 16.31 % | 18.60 % | 17.97 % | 19.55 % | 21.14 % | 19.95 % | 19.98 % | 22.29 % | 21.34 % | 21.12 % | 21.51 % |
| Government | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % |
| Public / Retail | 4.07 % | 3.99 % | 4.24 % | 4.03 % | 4.27 % | 4.48 % | 4.23 % | 4.13 % | 4.04 % | 3.90 % | 4.04 % | 3.70 % | 3.74 % | 3.81 % | 3.62 % | 3.65 % | 3.81 % | 3.98 % | 4.44 % | 4.70 % |
| Others | 56.73 % | 55.13 % | 53.47 % | 54.29 % | 53.73 % | 51.07 % | 51.63 % | 49.75 % | 48.64 % | 50.23 % | 47.80 % | 48.76 % | 1.52 % | 1.57 % | 1.50 % | 1.54 % | 1.60 % | 1.62 % | 1.99 % | 2.01 % |
| No of Share Holders | 67,091 | 75,153 | 98,452 | 99,135 | 1,26,226 | 1,46,320 | 1,35,923 | 1,31,636 | 1,31,937 | 1,20,030 | 1,31,565 | 1,19,578 | 1,30,664 | 1,27,754 | 1,19,245 | 1,27,802 | 1,34,058 | 1,41,007 | 1,60,556 | 1,78,648 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 6 | 5 | 6 | 6 | 3 | 11.75 | 15 | 16 | 12.66 | 0.00 |
| Dividend Yield (%) | 0.56 | 0.41 | 0.53 | 0.21 | 0.07 | 0.27 | 0.24 | 0.24 | 0.17 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 21 Aug 2021 |  Dividend | ₹ 3.00 /share | 18 Aug 2021 | 3,244.80 | 4,746.50 |
| 20 Aug 2022 | Dividend | ₹ 11.75 /share | 18 Aug 2022 | 3,524.30 | 4,135.35 |
| 24 Feb 2023 | Dividend | ₹ 6.00 /share | 24 Feb 2023 | 4,355.10 | 4,448.85 |
| 19 Aug 2023 | Dividend | ₹ 9.00 /share | 18 Aug 2023 | 4,646.10 | 4,848.35 |
| 20 Feb 2024 | Dividend | ₹ 6.00 /share | 20 Feb 2024 | 6,179.35 | 6,656.25 |
| 17 Aug 2024 | Dividend | ₹ 10.00 /share | 16 Aug 2024 | 5,903.45 | 6,686.90 |
| 30 Aug 2024 |  Annual General Meeting | NA | 30 Aug 2024 | 6,704.00 | 6,855.95 |
| 06 Nov 2024 |  Quarterly Result Announcement | NA | 06 Nov 2024 | 7,092.60 | 6,966.30 |
| 10 Feb 2025 | Quarterly Result Announcement | NA | 10 Feb 2025 | 6,828.10 | 6,790.55 |
| 15 Feb 2025 | Dividend | ₹ 9.00 /share | 14 Feb 2025 | 6,790.55 | 6,266.65 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 6,974.00 | 6,923.00 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 7,352.50 | 7,259.00 |
| 19 Aug 2025 | Dividend | ₹ 10.00 /share | 19 Aug 2025 | 6,923.00 | 7,822.50 |
| 29 Aug 2025 | Annual General Meeting | NA | 29 Aug 2025 | 6,923.00 | 7,726.60 |
| 06 Nov 2025 | Quarterly Result Announcement | NA | 06 Nov 2025 | 7,671.00 | 7,813.25 |
| 10 Feb 2026 | Quarterly Result Announcement | NA | 10 Feb 2026 | 7,272.50 | 7,211.30 |
| 16 Feb 2026 | Dividend | ₹ 10.00 /share | 16 Feb 2026 | 7,211.30 | 7,538.25 |
Announcements
Announcement under Regulation 30 (LODR)-Updates on Acquisition
2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Scheme of Arrangement2 days ago
2 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20185 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Scheme of Arrangement9 days ago
9 days agoBoard Meeting Outcome for Outcome Of The Board Meeting10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-AcquisitionMar 31, 2026
Mar 31, 2026Closure of Trading WindowMar 24, 2026
Mar 24, 2026Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations)Mar 23, 2026
Mar 23, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 14, 2026
Feb 14, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2026
Feb 12, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2026
Feb 10, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2026
Feb 10, 2026Announcement under Regulation 30 (LODR)-AcquisitionFeb 10, 2026
Feb 10, 2026Record DateFeb 10, 2026
Feb 10, 2026Corporate Action-Board approves DividendFeb 10, 2026
Feb 10, 2026Announcement under Regulation 30 (LODR)-Date of payment of DividendFeb 10, 2026
Feb 10, 2026Announcement under Regulation 30 (LODR)-Dividend UpdatesFeb 10, 2026
Feb 10, 2026Board Meeting Outcome for Announcement On Outcome Of The Board MeetingFeb 10, 2026
Feb 10, 2026Update on board meetingFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-Credit RatingJan 27, 2026
Jan 27, 2026Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 27, 2026
Jan 27, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 27, 2026
Jan 27, 2026Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations).Jan 21, 2026
Jan 21, 2026Board Meeting Intimation for Notice Of The Board MeetingJan 16, 2026
Jan 16, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Jan 16, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Closure of Trading WindowDec 26, 2025
Dec 26, 2025Subject: Receipt Of Observation Letter From The BSE Limited (BSE) In Relation To The Proposed Composite Scheme Of Arrangement Amongst Apollo Hospitals Enterprise Limited (Company) Apollo Healthco Limited (Transferor Company 1) Keimed Private Limited (TranDec 24, 2025
Dec 24, 2025Subject: Receipt Of Observation Letter With No Objection From The National Stock Exchange Of India Limited (NSE) In Relation To The Proposed Composite Scheme Of Arrangement Amongst Apollo Hospitals Enterprise Limited (Company) Apollo Healthco Limited (TraDec 24, 2025
Dec 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 11, 2025
Nov 11, 2025Intimation Of Receipt Of In - Principle Approval From BSE Limited And National Stock Exchange Of India Limited For Issue And Allotment Of Maximum Of 2156770 Equity Shares Of Rs.5/- Each Under Apollo Hospitals Enterprise Limited - Employee Stock Option PlaNov 08, 2025
Nov 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 06, 2025
Nov 06, 2025Board Meeting Outcome for Outcome Of Board MeetingNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 30, 2025
Oct 30, 2025Board Meeting Intimation for Notice Of The Board MeetingOct 14, 2025
Oct 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionOct 04, 2025
Oct 04, 2025Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations).Sep 24, 2025
Sep 24, 2025Closure of Trading WindowSep 23, 2025
Sep 23, 2025Announcement under Regulation 30 (LODR)-AcquisitionSep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 12, 2025
Sep 12, 2025Board Meeting Outcome for Outcome Of The Board MeetingSep 12, 2025
Sep 12, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 30, 2025
Aug 30, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29, 2025
Aug 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 29, 2025
Aug 29, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 52.72
ATR(14)
Less Volatile 180.72
STOCH(9,6)
Neutral 57.34
STOCH RSI(14)
Overbought 86.52
MACD(12,26)
Bullish 3.71
ADX(14)
Weak Trend 14.19
UO(9)
Bearish 52.68
ROC(12)
Uptrend And Accelerating 2.00
WillR(14)
Neutral -20.24
About Apollo Hospitals
Apollo Hospitals Enterprise Limited (AHEL) is a leading private healthcare provider in Asia. It operates a network of hospitals, pharmacies, primary care clinics, and diagnostic centers. As of March 31, 2023, AHEL had a capacity of 9,957 beds across 70 hospitals in India and overseas. This includes 8,544 beds in...more
Chairperson NamePreetha Reddy
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
